(Updated - January 22, 2019 9:18 AM EST)(updated to add analyst comment)Citi analyst Yigal Nochomovitz downgraded CRISPR Therapeutics (NASDAQ: CRSP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE